FRA:MDG1 • DE000A40ESG2
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDIGENE AG (MDG1.DE).
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.989M 25.60% | 31.247M 184.35% | 6.034M -80.69% | 11.22M 85.95% | 20.4M 81.82% | 8.16M -60.00% | 11.124M 36.32% | 14.248M 28.08% | 17.288M 21.34% | 22.418M 29.67% | |
| EBITDA YoY % growth | -6.557M 70.45% | 13.125M 300.17% | -14.686M -211.89% | -12.546M 14.57% | -12.24M 2.44% | -11.118M 9.17% | -10.517M 5.41% | -8.239M 21.66% | -8.05M 2.30% | -7.387M 8.24% | |
| EBIT YoY % growth | -9.985M 65.17% | -8.727M 12.60% | -16.149M -85.05% | -12.546M 22.31% | -4.631M 63.09% | -11.118M -140.09% | -10.517M 5.41% | -8.239M 21.66% | -8.05M 2.30% | -7.387M 8.24% | |
| Operating Margin | -90.86% | -27.93% | -267.63% | -111.82% | -22.70% | -136.25% | -94.54% | -57.83% | -46.56% | -32.95% | |
| EPS YoY % growth | N/A 36.60% | N/A 103.10% | N/A -3,756.00% | -0.92 38.46% | -0.81 12.22% | -0.52 35.44% | -0.46 12.53% | -0.35 23.00% | -0.27 21.63% | -0.25 10.33% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
8 analysts have analysed MDG1.DE and the average price target is 3.88 EUR. This implies a price increase of 2803.37% is expected in the next year compared to the current price of 0.1335.
MEDIGENE AG (MDG1.DE) will report earnings on 2025-08-12.
The number of analysts covering MEDIGENE AG (MDG1.DE) is 8.